Project U2 – Universal CAR T cell therapy in autoimmune and malignant disease

Basic data

Acronym:
U2
Title:
Universal CAR T cell therapy in autoimmune and malignant disease
Duration:
01/08/2017 to 01/08/2020
Abstract / short description:
Highly functional transgenic T cells are used for the treatment of autoimmune phenomena as well as for malignant disease while negative feedback mechanisms are abrogated
Keywords:
immunology
Immunologie

Involved staff

Managers

Faculty of Medicine
University of Tübingen
Faculty of Medicine
University of Tübingen

Contact persons

Faculty of Medicine
University of Tübingen
Faculty of Medicine
University of Tübingen

Local organizational units

Paediatrics Department I and Polyclinic
University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes, Faculty of Medicine

Funders

Tübingen, Baden-Württemberg, Germany
Help

will be deleted permanently. This cannot be undone.